Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Briefing
  • Published:

Immunomodulatory microbial metabolites as potential predictors of stem-cell transplantation outcomes

Microbiome diversity has been associated with improved outcomes after allogeneic stem-cell transplantation in patients with hematological cancers. Multimodal analysis of intestinal microbiome and metabolome data helped identify immunomodulatory microbial metabolites that were predictive of survival, transplant-related mortality and cancer relapse. These metabolites were products of short-chain-fatty-acid-synthesis pathways, and their associated genes were expressed by both bacterial species and bacteriophages.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Profiling of IMMs before and after allo-SCT to establish the IMM-RI.

References

  1. Peled, J. et al. Microbiota as predictor of mortality in allogeneic hematopoietic-cell transplantation. N. Eng. J. Med. 382, 822–834 (2020). This is an analysis of an international cohort that linked human microbiome to overall survival and transplantation-related mortality in allo-SCT.

    Article  CAS  Google Scholar 

  2. Swimm, A. et al. lndoles derived from intestinal microbiota act via type I interferon signalling to limit graft-versus-host disease. Blood 132, 2506–2519 (2018). This paper reports that microbiota-derived indole-3-carboxaldehyde provides protection against GvHD in mouse models of allo-SCT.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Argelaguet, R. et al. Multi-Omics Factor Analysis — a framework for unsupervised integration of multi-omics data sets. Mol. Syst. Biol. 14, e8124 (2018). This paper describes the MOFA framework for the integration of multi-omics datasets and identification of shared features.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Fischer, J. C. et al. RIG-I/MAVS and STING signalling promote gut integrity during irradiation­ and immune-mediated tissue injury. Sci. Transl. Med. 9, eaag2513 (2017). This paper shows that activators of type I interferon signaling can positively or negatively modulate GvHD, depending on timing.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Michonneau, D. et al. Metabolomics analysis of human acute graft-versus-host disease reveals changes in host and microbiota-derived metabolites. Nat. Commun. 10, 5695 (2019). This paper was the first to perform a comprehensive untargeted analysis of the metabolome in the blood of patients receiving allo-SCT.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This is a summary of: Thiele Orberg, E. et al. Bacteria and bacteriophage consortia are associated with protective intestinal metabolites in patients receiving stem cell transplantation. Nat. Cancer https://doi.org/10.1038/s43018-023-00669-x (2024).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Immunomodulatory microbial metabolites as potential predictors of stem-cell transplantation outcomes. Nat Cancer 5, 14–15 (2024). https://doi.org/10.1038/s43018-023-00670-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s43018-023-00670-4

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer